Systematic review and meta-analysis of ivermectin for treatment of COVID-19: evidence beyond the hype
MS Marcolino, KC Meira, NS Guimarães… - BMC Infectious …, 2022 - Springer
Background The role of ivermectin in the treatment of COVID-19 is still under debate, yet the
drug has been widely used in some parts of the world, as shown by impressive market data …
drug has been widely used in some parts of the world, as shown by impressive market data …
[HTML][HTML] Ivermectin for treatment of COVID-19: A systematic review and meta-analysis
Z Song, S Shi, Y Zhang - Heliyon, 2024 - cell.com
The effect of ivermectin (IVM) in treating coronavirus disease 2019 (COVID-19) is still
controversial, yet the drug has been widely used in the world. The aim of this review was to …
controversial, yet the drug has been widely used in the world. The aim of this review was to …
Ivermectin for treatment of mild-to-moderate COVID-19 in the outpatient setting: a decentralized, placebo-controlled, randomized, platform clinical trial
Accelerating COVID-19 Therapeutic Interventions and … - MedRxiv, 2022 - medrxiv.org
Background The effectiveness of ivermectin to shorten symptom duration or prevent
hospitalization among outpatients in the United States with mild-to-moderate symptomatic …
hospitalization among outpatients in the United States with mild-to-moderate symptomatic …
Correction: Awad et al. Repurposing Potential of the Antiparasitic Agent Ivermectin for the Treatment and/or Prophylaxis of COVID-19. Pharmaceuticals 2022, 15, 1068
H Awad, B Hassan, S Dweek, Y Aboelata… - …, 2024 - pmc.ncbi.nlm.nih.gov
The following paragraph,“Coinciding but insignificant findings with regards to the time to
negative PCR were established by Pott-Junior et al. in a randomized open-label study …
negative PCR were established by Pott-Junior et al. in a randomized open-label study …
Global trends in clinical trials of ivermectin for COVID-19—Part 2
M Yagisawa, PJ Foster, H Hanaki… - The Japanese Journal of …, 2024 - jstage.jst.go.jp
In March of 2021, when the third wave of the COVID-19 pandemic seemed to be under
control, the authors analyzed the circumstances that led to the global pandemic and …
control, the authors analyzed the circumstances that led to the global pandemic and …
[PDF][PDF] EVIDENCE SUMMARY
INV MD, AGQ Jiao, MM Alejandria, NAR Esteban-Ipac… - psmid.org
Ivermectin is an anti-parasitic drug repurposed as a potential therapy for COVID-19 because
of its antiviral properties and immunomodulatory effects. In-vitro studies show that ivermectin …
of its antiviral properties and immunomodulatory effects. In-vitro studies show that ivermectin …
[PDF][PDF] Ivermectin and outcomes from Covid 19 pneumonia: A systematic review and meta analysis of randomized clinical trial studies
A Kurniawan - researchgate.net
Ivermectin is an FDA approved drug for a parasitic disease that has broad antiviral activity.
This study aims to analyse the efficacy of ivermectin in improving the Covid 19 outcomes …
This study aims to analyse the efficacy of ivermectin in improving the Covid 19 outcomes …
イベルメクチンのCOVID-19 に対する臨床試験の世界的動向―その 2
八木澤守正， 花木秀明， 大村智 - The Japanese Journal of Antibiotics, 2024 - jstage.jst.go.jp
抄録 著者らが 2021 年 3 月に本誌に寄稿した総説では, 世界の 27 カ国から 91
件のイベルメクチンの COVID-19 に対する臨床試験が公的登録機関に登録されており, その中の …
件のイベルメクチンの COVID-19 に対する臨床試験が公的登録機関に登録されており, その中の …